Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An exploratory pilot study in healthy volunteers to assess the parameters for the design of bioequivalence studies on moderately lipophilic, moderately to highly protein bound drugs using dermal open flow microperfusion (dOFM) - FDA02_AIM2_Pilot

Trial Profile

An exploratory pilot study in healthy volunteers to assess the parameters for the design of bioequivalence studies on moderately lipophilic, moderately to highly protein bound drugs using dermal open flow microperfusion (dOFM) - FDA02_AIM2_Pilot

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2018

At a glance

  • Drugs Lidocaine/prilocaine (Primary)
  • Indications Anaesthesia
  • Focus Pharmacokinetics
  • Acronyms FDA02_AIM2_Pilot
  • Most Recent Events

    • 22 May 2018 Status changed from recruiting to completed.
    • 14 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top